際際滷

際際滷Share a Scribd company logo
The life and_times_of_biomet_1977-2012____trine
The Life and Times of Biomet
  Fiscal Years 1978  2012
         I U Kokomo
      Kokomo, Indiana

        February 12,
           2013
1977

   Incorporated in November
   8 Team Members
   Early Financing
   $725,000 Capital
           $500,000 SBA Guaranteed Loan
           $100,000 Revolving Line
           $125,000 Equity
1977

   Began Developing Major
    Technological Advances
       Titanium Alloy
        Reconstructive Products
       Direct Compression Molded
        Polyethylene
       Titanium Plasma Spray
        Porous Coating
1978

   Biomet Moved into Initial Facility
   $17,000 Net Sales
   $63,000 Net Loss
Recipient of Biomets 1st Hip Implant:
  Dane Millers Maternal Grandmother,
           Grace Shumaker
1978 - 1st Color Print Advertisement
   The Newest Manufacturer of Orthopedic Implants
        is Working Nearly Around the Clock
          Thats Why the Lights Are Still On
1979

   The Total Cruciate Condylar Knee
       Predecessor to the AGC Total Knee
       Incorporated Biomets 1st Compression
        Molded Tibial Component
1979
   Jerry & Kenneth Miller
       Provided Biomet with Early
        Equity Financing
       Served on Biomets Board
        of Directors for many years
1980

   $1.1 Million Net Sales
   Ground-Breaking for Current Site
       Financed by Sale of Economic
        Development Revenue Bonds
1981

   $1.25 Million Raised in Subordinated
    Debenture Offering
   Facility Completion
       23,000 Sq. Ft.
       3 Independent Locations Vacated (53 Team Members)
   Produced Biomets 1st Annual Report
       Theme: Not Just Another Year
1982
   $3.5 Million Net Sales
   $1.25 Million Raised through Initial Public Offering
1983
   AGC Total Knee
       1st System to Offer Complete
        Component Interchangeability
       Top Performer with Excellent
        Clinical Results
   March Stock Split: 2 for 1
   July Stock Split: 2 for 1
   $11.9 Million Raised in
    Secondary Public Offering
1984

   Introduction of Titanium Plasma
    Spray Porous Coating
   Acquisition of Orthopedic
    Equipment Company
       Expanded Biomets Worldwide
        Market Presence
   $10.6 Million Net Sales
1984



   Indiana Small Business
    Person of the Year
   Meeting with President Reagan
1985
   New Products
       Bi-Metric Hip for cementless
        or cemented implantation
       AGC Calibrated Distractor
       Redi-Drape
1986

    Stock Split: 2 for 1
    $44.1 Million Net Sales
    $24.7 Million Raised in
     Secondary Public Offering
1986

   Groundbreaking for 3rd Building
    Addition of 66,000 Sq. Ft.
   $500,000 SBA Loan Retired Early
       Estimated $9 Million Combined
        Corporate & Personal Tax Revenues
        Collected as Result of Funding
1987

   Biomet Gaining National
    Media Exposure as Hot
    Growth Company
1988
   Acquisition of EBI
       Leader in Electrical Stimulation &
        External Fixation Markets
   New plant in Swindon,
    England Replaced
    Leased Facilities
   $97.6 Million Net Sales
   Stock Split: 3 for 2
1989

   Introduction of Bi-Angular
    Total Shoulder System
   Stock Split: 3 for 2
   1,000 Team Members
   Indiana Business Publication Names
    Miller Entrepreneur of the Year
    for High Technology Sector
1990
   $162.4 Million Net Sales
   EBI Introduces SpF-T Line of Spinal
    Fusion Stimulators
1991

   President George Bush presented Small Business
    Administration National Entrepreneurial Success
    Award to Miller & Noblitt
   Biomet Led Forbes Honor Role of Small
    Publicly Traded Companies
1991

   January Stock Split: 2 for 1
   3-Story 43,000 Sq. Ft. Facility Expansion
   11,000 Sq. Ft. Building Constructed in
    Warsaw for Resorbable Material Technologies
   December Stock Split: 2 for 1
1992

   $274.8 Million Net Sales
   Acquisition of Lorenz Surgical in
    Jacksonville
       Market Leader in Craniomaxillofacial
        Fixation Products
1993

   Swedish Knee Study Reported AGC Knee
    Had Lowest Revision Rate of Knees in Study
   Introduction of Maxim Total Knee System
   1,760 Team Members
   Biomet 3rd on Hoosier Top 50 List
1994
   $373.3 Million Net Sales
   $25 Million Share Repurchase Program
   Acquisition of Kirschner
       Reconstructive & Softgoods Products
       Performance Knee
       Casting Facility in New Jersey
       Mfg. Plant in Spain
1995

   27% Increase in
    International Sales
   ArCom Argon Packaged,
    Compression Molded
    Polyethylene
1996

   Mallory-Head Modular Calcar
    Revision Series Introduced
      Provides Customized
       Fixation Alternatives
   Launch of EBI DynaFix
    External Fixation System
   $535.2 Million Net Sales
1996
   60,000 Sq. Ft. Addition to Lorenz Surgical
      Manufacturing
      R&D
1997

   Introduction of Indiana Tome
    Carpal Tunnel Release System
   $580.3 Million Net Sales
   2,500 Team Members
   26 Facilities totaling 1,071,000
    Sq. Ft.
   EBI Launched SpineLink
    Fixation System
1998
   Biomet Merck JV
   European Launch of TRAC
    Mobile Bearing Knee
   $651.4 Million Net Sales
   2,750 Team Members
   Ascent Total Knee System
    Launched
   Omega 21 Spinal Fixation &
    SpineLink Anterior Cervical
    Systems Introduced
1999
   Alliance with Selective Genetics to
    Develop Gene Therapy Products
   $757.4 Million Net Sales
   Introduction of Mimix Bone
    Substitute Material
   Biomet Entered Worldwide Dental
    Reconstructive Implant Market
    with Acquisition of 3i
2000
   M2a Metal-On-Metal Hip
    Articulation System
   $920.6 Million Net Sales
   Stock Split: 3 for 2
   Biolectron Acquisition
    Added Non-Invasive
    Electrical Stimulation
   4,000 Team Members
2001
   Approximately 100 New Products
    & Line Extensions
   $1 Billion Net Sales
   Stock Split: 3 for 2
   Over 270 Million Shares
   4,600 Team Members
   1,500+ Sales
    Representatives
2002

   Approximately 80 New Products
   $1.2 Billion Net Sales
   More than 50 Facilities
    (18 Manufacturing)
   4,900 Team Members
   1,850 Sales Representatives
   Share Repurchase Program Initiated
2003
   Approximately 85 New Products
   Reintroduction of Constrained Liners
   Microplasty Minimally-Invasive
    Instrumentation
   $1.4 Billion Net Sales
   Expansion of Share Repurchase
    Program
   50% Dividend Increase to $0.15
   5,000+ Team Members
   2,000+ Sales Representatives
2004
   $1.6 Billion Net Sales
   Expansion of Share
    Repurchase Program
   33% Dividend Increase to $0.20
   Q4 Introduction of Vanguard
    Complete Knee System
   ReCap Femoral Resurfacing
   5,300+ Team Members
   2,200+ Sales Representatives
2005
   $1.9 Billion Net Sales
   Rollout of Vanguard Knee
   Domestic Introduction of Oxford Partial Knee
   25% Dividend Increase to $0.25
   Expansion of Share Repurchase Program
   500+ New Products Introduced Over the Past 6 Years
   6,000+ Team Members
   2,400+ Sales Representatives
2006
   $2.0 Billion Net Sales
   Co-Founder, President/CEO
    Dane A. Miller, Ph.D. Announces Retirement
   Launch of C2a-Taper Acetabular System
   Introduction of Vanguard SSK
    (Super Stabilized Knee) Revision System
   20% Dividend Increase to $0.30
   600+ New Products Introduced Over the Past
    7 Years
   6,300 Team Members
   2,600 Sales Representatives
2007
   $2.1 Billion Net Sales
   Company Signs Definitive Merger
    Agreement With Private Equity Consortium
   Jeffrey R. Binder Named President/CEO
   Launch of E-Poly (Vitamin E Stabilized Highly
    Crosslinked Polyethylene)
   Introduction of NanoTite Dental Implant
   700+ New Products Introduced Over
    the Past 8 Years
   6,500 Team Members
   2,700+ Sales Representatives
2008
   $2.4 Billion Net Sales
   Completion of the Merger with LVB Acquisition Merger
    Sub, Inc.
   Launch of the Taperloc and the Balance Microplasty Stems
   25th Anniversary of Taperloc Hip Stem is Celebrated
   Launch of One Patient, our U.S. Advocacy Initiative
      Biomet products are used to help one surgeon treat one
        patient, 1 million times per year
      www.onepatient.us
   ~800 New Products Introduced Over the Past 9 Years
   7,200+ Team Members
   3,000+ Sales Representatives
2009
   $2.5 Billion Net Sales
   12% Adjusted EBITDA Growth
   12% Constant Currency Growth for Global Orthopedic
    Reconstructive Device Sales
   Strong Market Acceptance of New Technologies, Including:
      E1 Antioxidant Infused Bearing Technology
      Regenerex Porous Titanium Construct components
      Signature Personalized Patient Care pre-operative planning
        software program, including patient-specific alignment guides
   7,200+ Team Members
   3,000+ Sales Representatives
   ~900 New Products Introduced Over the Past 10 Years
2010
   $2.7 Billion Net Sales
   8% Adjusted EBITDA Growth
   10% CC Growth for Global Orthopedic Reconstructive Device Sales
   Acquired Assets of Cartilix  Cartilage Repair Technology
   Dane A. Miller, Ph.D., Co-Founder, Former CEO, and Current Board Member
    Named 2009 Phoenix Lifetime Achievement Award Winner
   Donated $3.1 Million in Medical Devices for the Haitian Relief Effort
   Q1 Introduction of Comprehensive Reverse Shoulder
   Introduced Cobalt MV (Medium Viscosity) Bone Cement for Total Joint Reconstruction
   ~ 7,500 Team Members
   3,000+ Sales Representatives
   900+ New Products Introduced Over the Past 11 Years
2011
   $2.7 Billion Net Sales
   Receive FDA Clearance for Active Articulation E1 Dual Mobility Hip System
   Acquisition of Substantially all of the Assets of Cytosol Laboratories, Inc.
   Biomet 3i collaborates with Renishaw PLC Providing the Latest Digital Dentistry
    Solutions to Laboratories, Dental Implant Professionals and Patients
   Biomet Sports Medicines JuggerKnot Soft Anchor Receives 2011 Medical Design
    Excellence Award
   ~ 7,500 Team Members
   3,000+ Sales Representatives
   900+ New Products Introduced Over the Past 12 Years
2012
   $2.8 Billion Net Sales
   Company Announces Offer to Acquire DePuy Trauma Business
   FDA Clearance for Two New Products:
      E1 Humeral Bearing for the Comprehensive Reverse Shoulder System
      The Comprehensive Segmental Revision System
   Company Celebrates 35 Years of Clinical Experience with the Oxford Partial Knee
    System
   8,000 Team Members
   3,000+ Sales Representatives
   Global Footprint With Operations in 50+ Location

More Related Content

The life and_times_of_biomet_1977-2012____trine

  • 2. The Life and Times of Biomet Fiscal Years 1978 2012 I U Kokomo Kokomo, Indiana February 12, 2013
  • 3. 1977 Incorporated in November 8 Team Members Early Financing $725,000 Capital $500,000 SBA Guaranteed Loan $100,000 Revolving Line $125,000 Equity
  • 4. 1977 Began Developing Major Technological Advances Titanium Alloy Reconstructive Products Direct Compression Molded Polyethylene Titanium Plasma Spray Porous Coating
  • 5. 1978 Biomet Moved into Initial Facility $17,000 Net Sales $63,000 Net Loss
  • 6. Recipient of Biomets 1st Hip Implant: Dane Millers Maternal Grandmother, Grace Shumaker
  • 7. 1978 - 1st Color Print Advertisement The Newest Manufacturer of Orthopedic Implants is Working Nearly Around the Clock Thats Why the Lights Are Still On
  • 8. 1979 The Total Cruciate Condylar Knee Predecessor to the AGC Total Knee Incorporated Biomets 1st Compression Molded Tibial Component
  • 9. 1979 Jerry & Kenneth Miller Provided Biomet with Early Equity Financing Served on Biomets Board of Directors for many years
  • 10. 1980 $1.1 Million Net Sales Ground-Breaking for Current Site Financed by Sale of Economic Development Revenue Bonds
  • 11. 1981 $1.25 Million Raised in Subordinated Debenture Offering Facility Completion 23,000 Sq. Ft. 3 Independent Locations Vacated (53 Team Members) Produced Biomets 1st Annual Report Theme: Not Just Another Year
  • 12. 1982 $3.5 Million Net Sales $1.25 Million Raised through Initial Public Offering
  • 13. 1983 AGC Total Knee 1st System to Offer Complete Component Interchangeability Top Performer with Excellent Clinical Results March Stock Split: 2 for 1 July Stock Split: 2 for 1 $11.9 Million Raised in Secondary Public Offering
  • 14. 1984 Introduction of Titanium Plasma Spray Porous Coating Acquisition of Orthopedic Equipment Company Expanded Biomets Worldwide Market Presence $10.6 Million Net Sales
  • 15. 1984 Indiana Small Business Person of the Year Meeting with President Reagan
  • 16. 1985 New Products Bi-Metric Hip for cementless or cemented implantation AGC Calibrated Distractor Redi-Drape
  • 17. 1986 Stock Split: 2 for 1 $44.1 Million Net Sales $24.7 Million Raised in Secondary Public Offering
  • 18. 1986 Groundbreaking for 3rd Building Addition of 66,000 Sq. Ft. $500,000 SBA Loan Retired Early Estimated $9 Million Combined Corporate & Personal Tax Revenues Collected as Result of Funding
  • 19. 1987 Biomet Gaining National Media Exposure as Hot Growth Company
  • 20. 1988 Acquisition of EBI Leader in Electrical Stimulation & External Fixation Markets New plant in Swindon, England Replaced Leased Facilities $97.6 Million Net Sales Stock Split: 3 for 2
  • 21. 1989 Introduction of Bi-Angular Total Shoulder System Stock Split: 3 for 2 1,000 Team Members Indiana Business Publication Names Miller Entrepreneur of the Year for High Technology Sector
  • 22. 1990 $162.4 Million Net Sales EBI Introduces SpF-T Line of Spinal Fusion Stimulators
  • 23. 1991 President George Bush presented Small Business Administration National Entrepreneurial Success Award to Miller & Noblitt Biomet Led Forbes Honor Role of Small Publicly Traded Companies
  • 24. 1991 January Stock Split: 2 for 1 3-Story 43,000 Sq. Ft. Facility Expansion 11,000 Sq. Ft. Building Constructed in Warsaw for Resorbable Material Technologies December Stock Split: 2 for 1
  • 25. 1992 $274.8 Million Net Sales Acquisition of Lorenz Surgical in Jacksonville Market Leader in Craniomaxillofacial Fixation Products
  • 26. 1993 Swedish Knee Study Reported AGC Knee Had Lowest Revision Rate of Knees in Study Introduction of Maxim Total Knee System 1,760 Team Members Biomet 3rd on Hoosier Top 50 List
  • 27. 1994 $373.3 Million Net Sales $25 Million Share Repurchase Program Acquisition of Kirschner Reconstructive & Softgoods Products Performance Knee Casting Facility in New Jersey Mfg. Plant in Spain
  • 28. 1995 27% Increase in International Sales ArCom Argon Packaged, Compression Molded Polyethylene
  • 29. 1996 Mallory-Head Modular Calcar Revision Series Introduced Provides Customized Fixation Alternatives Launch of EBI DynaFix External Fixation System $535.2 Million Net Sales
  • 30. 1996 60,000 Sq. Ft. Addition to Lorenz Surgical Manufacturing R&D
  • 31. 1997 Introduction of Indiana Tome Carpal Tunnel Release System $580.3 Million Net Sales 2,500 Team Members 26 Facilities totaling 1,071,000 Sq. Ft. EBI Launched SpineLink Fixation System
  • 32. 1998 Biomet Merck JV European Launch of TRAC Mobile Bearing Knee $651.4 Million Net Sales 2,750 Team Members Ascent Total Knee System Launched Omega 21 Spinal Fixation & SpineLink Anterior Cervical Systems Introduced
  • 33. 1999 Alliance with Selective Genetics to Develop Gene Therapy Products $757.4 Million Net Sales Introduction of Mimix Bone Substitute Material Biomet Entered Worldwide Dental Reconstructive Implant Market with Acquisition of 3i
  • 34. 2000 M2a Metal-On-Metal Hip Articulation System $920.6 Million Net Sales Stock Split: 3 for 2 Biolectron Acquisition Added Non-Invasive Electrical Stimulation 4,000 Team Members
  • 35. 2001 Approximately 100 New Products & Line Extensions $1 Billion Net Sales Stock Split: 3 for 2 Over 270 Million Shares 4,600 Team Members 1,500+ Sales Representatives
  • 36. 2002 Approximately 80 New Products $1.2 Billion Net Sales More than 50 Facilities (18 Manufacturing) 4,900 Team Members 1,850 Sales Representatives Share Repurchase Program Initiated
  • 37. 2003 Approximately 85 New Products Reintroduction of Constrained Liners Microplasty Minimally-Invasive Instrumentation $1.4 Billion Net Sales Expansion of Share Repurchase Program 50% Dividend Increase to $0.15 5,000+ Team Members 2,000+ Sales Representatives
  • 38. 2004 $1.6 Billion Net Sales Expansion of Share Repurchase Program 33% Dividend Increase to $0.20 Q4 Introduction of Vanguard Complete Knee System ReCap Femoral Resurfacing 5,300+ Team Members 2,200+ Sales Representatives
  • 39. 2005 $1.9 Billion Net Sales Rollout of Vanguard Knee Domestic Introduction of Oxford Partial Knee 25% Dividend Increase to $0.25 Expansion of Share Repurchase Program 500+ New Products Introduced Over the Past 6 Years 6,000+ Team Members 2,400+ Sales Representatives
  • 40. 2006 $2.0 Billion Net Sales Co-Founder, President/CEO Dane A. Miller, Ph.D. Announces Retirement Launch of C2a-Taper Acetabular System Introduction of Vanguard SSK (Super Stabilized Knee) Revision System 20% Dividend Increase to $0.30 600+ New Products Introduced Over the Past 7 Years 6,300 Team Members 2,600 Sales Representatives
  • 41. 2007 $2.1 Billion Net Sales Company Signs Definitive Merger Agreement With Private Equity Consortium Jeffrey R. Binder Named President/CEO Launch of E-Poly (Vitamin E Stabilized Highly Crosslinked Polyethylene) Introduction of NanoTite Dental Implant 700+ New Products Introduced Over the Past 8 Years 6,500 Team Members 2,700+ Sales Representatives
  • 42. 2008 $2.4 Billion Net Sales Completion of the Merger with LVB Acquisition Merger Sub, Inc. Launch of the Taperloc and the Balance Microplasty Stems 25th Anniversary of Taperloc Hip Stem is Celebrated Launch of One Patient, our U.S. Advocacy Initiative Biomet products are used to help one surgeon treat one patient, 1 million times per year www.onepatient.us ~800 New Products Introduced Over the Past 9 Years 7,200+ Team Members 3,000+ Sales Representatives
  • 43. 2009 $2.5 Billion Net Sales 12% Adjusted EBITDA Growth 12% Constant Currency Growth for Global Orthopedic Reconstructive Device Sales Strong Market Acceptance of New Technologies, Including: E1 Antioxidant Infused Bearing Technology Regenerex Porous Titanium Construct components Signature Personalized Patient Care pre-operative planning software program, including patient-specific alignment guides 7,200+ Team Members 3,000+ Sales Representatives ~900 New Products Introduced Over the Past 10 Years
  • 44. 2010 $2.7 Billion Net Sales 8% Adjusted EBITDA Growth 10% CC Growth for Global Orthopedic Reconstructive Device Sales Acquired Assets of Cartilix Cartilage Repair Technology Dane A. Miller, Ph.D., Co-Founder, Former CEO, and Current Board Member Named 2009 Phoenix Lifetime Achievement Award Winner Donated $3.1 Million in Medical Devices for the Haitian Relief Effort Q1 Introduction of Comprehensive Reverse Shoulder Introduced Cobalt MV (Medium Viscosity) Bone Cement for Total Joint Reconstruction ~ 7,500 Team Members 3,000+ Sales Representatives 900+ New Products Introduced Over the Past 11 Years
  • 45. 2011 $2.7 Billion Net Sales Receive FDA Clearance for Active Articulation E1 Dual Mobility Hip System Acquisition of Substantially all of the Assets of Cytosol Laboratories, Inc. Biomet 3i collaborates with Renishaw PLC Providing the Latest Digital Dentistry Solutions to Laboratories, Dental Implant Professionals and Patients Biomet Sports Medicines JuggerKnot Soft Anchor Receives 2011 Medical Design Excellence Award ~ 7,500 Team Members 3,000+ Sales Representatives 900+ New Products Introduced Over the Past 12 Years
  • 46. 2012 $2.8 Billion Net Sales Company Announces Offer to Acquire DePuy Trauma Business FDA Clearance for Two New Products: E1 Humeral Bearing for the Comprehensive Reverse Shoulder System The Comprehensive Segmental Revision System Company Celebrates 35 Years of Clinical Experience with the Oxford Partial Knee System 8,000 Team Members 3,000+ Sales Representatives Global Footprint With Operations in 50+ Location